Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2.262 JPY | -0,35% | +1,18% | -10,00% |
Vakgebied
Aantal werknemers: 3 761
Verkoop per activiteit
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 361 361 | 100,0 % | 447 187 | 100,0 % | +23,75% |
Verkoop per regio
JPY in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Japan
64,4
%
| 241 971 | 67,0 % | 288 155 | 64,4 % | +19,09% |
Americas
31,9
%
| 105 890 | 29,3 % | 142 791 | 31,9 % | +34,85% |
Asia
2,6
%
| 8 895 | 2,5 % | 11 625 | 2,6 % | +30,69% |
Europe
1,0
%
| 4 605 | 1,3 % | 4 616 | 1,0 % | +0,24% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gyo Sagara
CEO | Chief Executive Officer | 65 | 01-04-83 |
Toichi Takino
PSD | President | 55 | - |
Director/Board Member | 64 | 01-04-85 | |
Isao Ono
BRD | Director/Board Member | 65 | 01-04-81 |
Kiyoaki Idemitsu
BRD | Director/Board Member | 60 | 01-06-21 |
Kei Sano
BRD | Director/Board Member | 64 | 01-04-83 |
Director/Board Member | 59 | - | |
Moriki Ishizaki
IRC | Investor Relations Contact | - | - |
Shinji Takai
PRN | Corporate Officer/Principal | - | - |
Katsunori Morio
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Shusaku Nagae
BRD | Director/Board Member | 74 | - |
Gyo Sagara
CEO | Chief Executive Officer | 65 | 01-04-83 |
Director/Board Member | 64 | 01-04-85 | |
Shozo Matsuoka
PRN | Corporate Officer/Principal | 64 | 01-04-85 |
Yutaka Kato
BRD | Director/Board Member | 70 | 01-06-13 |
Hiroshi Ichikawa
SAM | Sales & Marketing | 62 | 01-04-84 |
Toichi Takino
PSD | President | 55 | - |
Director/Board Member | 59 | - | |
Kiyoaki Idemitsu
BRD | Director/Board Member | 60 | 01-06-21 |
Akiko Okuno
BRD | Director/Board Member | - | - |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 498 692 800 | 378 124 547 ( 75,82 %) | 42 672 518 ( 8,557 %) | 75,82 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
28 980 082 | 5.81% | 469 996 362 $ | |
DAIKIN INDUSTRIES, LTD. 0.29% | 850 500 | 0.29% | 115 763 979 $ |
2 951 997 | 0.96% | 81 921 341 $ | |
6 204 000 | 1.70% | 62 984 869 $ | |
T&D HOLDINGS INC. 0.62% | 3 386 010 | 0.62% | 58 113 311 $ |
1 348 400 | 0.97% | 51 006 574 $ | |
KIKKOMAN CORPORATION 0.37% | 3 585 000 | 0.37% | 46 640 886 $ |
YAKULT HONSHA CO.,LTD. 0.47% | 1 614 800 | 0.47% | 33 278 670 $ |
725 200 | 0.62% | 30 192 505 $ | |
SHIMADZU CORPORATION 0.31% | 919 000 | 0.31% | 25 685 489 $ |
Bedrijfsgegevens
Ono Pharmaceutical Co., Ltd.
1-8-2 Kyutaromachi Chuo-Ku
541-8564, Osaka
+81 6 6263 5670
http://www.ono.co.jpSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-10,00% | 6,95 mld. | |
+18,74% | 22,25 mld. | |
+13,49% | 14,39 mld. | |
+12,83% | 13,55 mld. | |
+38,02% | 11,27 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+6,35% | 5,01 mld. | |
-5,36% | 4,51 mld. | |
+2,40% | 4,51 mld. |
- Beurs
- Aandelen
- Koers 4528
- Onderneming Ono Pharmaceutical Co., Ltd.